GL1X · GenesisL1 explorer

Research workbench

Structural basis for the inhibition of E. COLI PBP2

Analyse Structural basis for the inhibition of E. COLI PBP2 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6G9F
Type
protein
Length
539 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peptidoglycan D,D-transpeptidase mrda
EC
3.4.16.4
UniProt
P0AD65
Ligands
NXL
Pockets
5 · best druggability 0.63

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APeptidoglycan D,D-transpeptidase mrda (EC 3.4.16.4)protein53937% helix, 23% strandP0AD65

Ligands and binding sites

  • NXL · (2S,5R)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carboxamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14330.630.7749empty
21520.430.7529NXL
31250.420.7620empty
4630.360.7813empty
5550.300.7514empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 6G9F · Structural basis for the inhibition of E. coli PBP2 · the same entry in another collection · chain A against A, TM-score 1.00
  • P0AD65 · AlphaFold monomer V2.0 prediction for peptidoglycan D,D-transpeptidase mrda (P0AD65) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.